Pranlukast, Leukotriene CysLT1 antagonist; GPR17 antagonist (TBI2441)
$90.00 – $351.00
Leukotriene CysLT1 antagonist; GPR17 antagonist
SKU | Stock | SIZE (mg) | Price | Quantity | ||
---|---|---|---|---|---|---|
TBI2441-50MG | Yes | 50 MG | $90.00 | |||
TBI2441-250MG | Yes | 250 MG | $351.00 |
- Description
- Terms
- Additional information
- Documents
- Reviews (0)
Description
Product Details
Formal Name: N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide
Alternate Names: ONO 1078
Molecular Formula: C27H23N5O4
Formula Weight: 481.51
CAS Number: 103177-37-3
Purity: >98%
Formulation: powder
Solubility: Soluble in DMSO (up to 25 mg/ml)
Storage: RT
Stability: ≥ 1 year.
Applications
Leukotriene CysLT1 antagonist; GPR17 antagonist
Functions
Pranlukast is a selective Leukotriene CysLT1 antagonist and has been used in the treatment of asthma. Pranlukast is also an inhibitor of GPR17 (IC50’s = 10.5nM hGPR17, 31nM rGPR17) and is superior to Montelukast in achieving functional inhibition.
Application Procedures
First dissolved in DMSO (up to 25 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 1 month.
Additional information
SIZE (mg) | 250 MG, 50 MG |
---|
Be the first to review “Pranlukast, Leukotriene CysLT1 antagonist; GPR17 antagonist (TBI2441)”
You must be logged in to post a review.
Reviews
There are no reviews yet.